This page shows the latest SOBI news and features for those working in and with pharma, biotech and healthcare.
While the deal was approved by the Sobi board, it was conditional on 90% of shareholders agreeing. ... We have a strong belief in Sobi’s strategy and the opportunities ahead.
patients. This is EMA’s latest review of a potential coronavirus treatment, following announcements that it is evaluating an arthritis drug developed by Sweden’s Sobi to treat COVID-19 in
Sobi requested that the CHMP re-examine the application for Gamifant (emapalumab) as a treatment for of primary haemophagocytic lymphohistiocytosis (HLH) after the Committee initially rejected the drug in July. ... In the US, over 100 primary HLH
Sobi has said it plans to request a re-examination by the CHMP and expects a subsequent opinion by the end of the year. ... The product has been able to make a substantial difference for a very vulnerable group of patients in the US,” said Guido Oelkers
Hopes to boost haematology franchise with lead drug Doptelet. Dova Pharmaceuticals is set to be acquired by Swedish Orphan Biovitrum AB (Sobi) for up to $915m, dependent on the regulatory approval ... Under the terms of the agreement, Sobi will offer a
Earlier this year, AstraZeneca picked up a PRV from Sobi for $95m.
More from news
Approximately 13 fully matching, plus 15 partially matching documents found.
Heggie has lots of experience in the rare disease field, having served in senior roles at Shire, as a board member at Sobi and as CEO of German rare disease biotech
Sobi’s Neil Dugdale on how the UK’s approach to rare diseases is changing. ... An exciting time. For Neil's company Sobi it's certainly been a busy time this year.
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Most recently, Levin worked as the president of Sobi, where he was responsible for building the organisation and developing the strategic growth pillars of the company. ... Prior to Sobi, Levin held commercial leadership roles of increasing strategic
Sobi appoints head of technical operations. Rare disease specialist company Sobi has appointed Anne Marie de Jonge Schuermans to front its new technical operations organisation. ... operations. She joins Sobi from Biogen, where she served as vice
Swedish Orphan Biovitrum (Sobi) has appointed Fredrik Wetterlundh as head of human resources and will simultaneously be part of Sobi’s extended leadership team. ... Guido Oelkers, CEO and president of Sobi, said: “His experience from the
Wills Hughes-Wilson joins the group from Sobi. London, UK-based Mereo BioPharma, has strengthened its team with the addition of Wills Hughes-Wilson, who joins the biopharma as its new ... In this role, Hughes-Wilson was responsible for Sobi’s
Rare disease firm Sobi has appointed Holly May as its new vice president of sales and marketing for the US. ... May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country.
More from appointments
Approximately 9 fully matching, plus 6 partially matching documents found.
LifeArc. Sobi. “We are a proud supporter of RARE Youth Revolution and we are absolutely thrilled to have them as part of the Breaking Down Barriers project!
Kyowa Kirin. Sobi. Theramex. Veriton Pharma. Vifor Pharma.
Novo Nordisk. Nutricia. Nutricia Global. SOBI. Target Ovarian Cancer. Trudell Medical.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...